Delivery Order SPE2DB24D2101-SPE2DB25FKHDN
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a ceiling value of $9,302.20 and a performance period through March 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. This contract is part of a larger...
This is a delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a firm fixed price of $13,640.10 and a completion date of December 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $10,987.05 contract is for the supply of LEQVIO 284 MG/1.5 ML syringes, a specialty pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Department of Defense (DoD) Medical Supply Chain (VPDLATSMED-A). The contract is for $10,987.05 and provides the DoD with the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,894 units of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $13,184.46 delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp has a longstanding relationship with DLA Troop Support Medical as a prime contractor providing pharmaceuticals, medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,197.41 firm fixed price delivery order contract to provide LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The award has a Firm Fixed Price contract type and a ceiling value of $4,651.10. The contract has an ultimate completion date of January 30, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LEQVIO 284 MG/1.5 ML syringes. This $4,394.82 delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support the Department of Defense. The contract has an...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,197.41 firm fixed-price delivery order is for the supply of 4564977632 - LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a performance period ending on July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...